The biological origin of Mauve Factor is unknown. Over decades, serious consideration has been given to dietary sources and porphyrins such as heme (deep red, non protein, ferrous component of hemoglobin). It is now well understood that activated vitamin B6 in combination with Zinc piccolinate is usually sufficient in suppressing mauve factor to achieve an optimal symptomatic response (McGinnis, Audhya, Walsh, Jackson, McLaren-Howard, Lewis, Lauda, Bibus, Jurnak, Lietha & Hoffer, 2008). In a recent review, researchers involved in the New Zealand Oxidative Stress in Autism Study, examined the relationship between nutritional status, oxidative stress (imbalance between pro-oxidants and antioxidants/the delivery of free radicals to your cells through breathing) and Mauve factor. In this review, it was reported that vitamin B6, at a dosage of 200 to 800 mg, in combination with zinc, at a dosage of 25 to 100 mg, will strongly assist in suppressing mauve factor. Moreover, suppression of manganese may result from aggressive zinc supplementation, and for this reason, small doses of maganese, approximately 5 mg for each 30 mg of supplemental zinc is recommended.
It is also reported that the double bonds in omega 3 and omega 6 fatty acids are vulnerable to oxidative stress. This being so, there is concern that the foregoing fatty acids may be depleted in subjects with elevated levels of Mauve. There is evidence to suggest that omega 3 supplementation and omega 6 supplementation, in the form of evening primrose oil (a rich source of gamma linolenic acid) is beneficial to individuals with elevated mauve factor as it can rapidly lower intestinal permeability (leaky gut syndrome). For this reason, the use of antioxidants such as glutathione or coenzyme Q 10 may be of benefit in reducing fatty acid vulnerability to oxidative stress.
Given that Mauve Factor is a metabolic disorder it is suggested that an ongoing deficiency in zinc, vitamin B6, biotin and manganese can result in brain dysfunction, increased cardiovascular risk, miscarriage, allergy, some forms of cancer and elevated sensitivity to emotional stress.
McGinnis, W.R., Audhya, T., Walsh, W.J., Jackson, J.A., McLaren-Howard, J., Lewis, A., Lauda, P.H., Bibus, D.M., Jurnak, F., Lietha, R. & Hoffer, A. 2008. Discerning the Mauve Factor, Part 2. Alternative Therapeutic Health Medicine, 14, 3, 56-62.
